| 000 | 01907 a2200601 4500 | ||
|---|---|---|---|
| 005 | 20250517165754.0 | ||
| 264 | 0 | _c20180427 | |
| 008 | 201804s 0 0 eng d | ||
| 022 | _a1445-5994 | ||
| 024 | 7 |
_a10.1111/imj.13502 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLee, Oi Lin | |
| 245 | 0 | 0 |
_aBisphosphonate guidelines for treatment and prevention of myeloma bone disease. _h[electronic resource] |
| 260 |
_bInternal medicine journal _cAug 2017 |
||
| 300 |
_a938-951 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aBisphosphonate-Associated Osteonecrosis of the Jaw _xetiology |
| 650 | 0 | 4 |
_aBone Density Conservation Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aBone Neoplasms _xcomplications |
| 650 | 0 | 4 | _aBone and Bones |
| 650 | 0 | 4 |
_aDiphosphonates _xadministration & dosage |
| 650 | 0 | 4 | _aEvidence-Based Medicine |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aKidney Diseases _xetiology |
| 650 | 0 | 4 |
_aMultiple Myeloma _xcomplications |
| 650 | 0 | 4 | _aPractice Guidelines as Topic |
| 650 | 0 | 4 | _aRadiography |
| 650 | 0 | 4 | _aRisk Factors |
| 700 | 1 | _aHorvath, Noemi | |
| 700 | 1 | _aLee, Cindy | |
| 700 | 1 | _aJoshua, Doug | |
| 700 | 1 | _aHo, Joy | |
| 700 | 1 | _aSzer, Jeff | |
| 700 | 1 | _aQuach, Hang | |
| 700 | 1 | _aSpencer, Andrew | |
| 700 | 1 | _aHarrison, Simon | |
| 700 | 1 | _aMollee, Peter | |
| 700 | 1 | _aRoberts, Andrew W | |
| 700 | 1 | _aTalaulikar, Dipti | |
| 700 | 1 | _aBrown, Ross | |
| 700 | 1 | _aAugustson, Bradley | |
| 700 | 1 | _aLing, Silvia | |
| 700 | 1 | _aJaksic, Wilfrid | |
| 700 | 1 | _aGibson, John | |
| 700 | 1 | _aKalff, Anna | |
| 700 | 1 | _aJohnston, Anna | |
| 700 | 1 | _aKalro, Akash | |
| 700 | 1 | _aWard, Chris | |
| 700 | 1 | _aPrince, H Miles | |
| 700 | 1 | _aZannettino, Andrew | |
| 773 | 0 |
_tInternal medicine journal _gvol. 47 _gno. 8 _gp. 938-951 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/imj.13502 _zAvailable from publisher's website |
| 999 |
_c27440137 _d27440137 |
||